Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era.
作者： Edward M. Behrens , Gary A. Koretzky
DOI: 10.1002/ART.40071
关键词:
摘要:
sci-hub.se 参考文章(71)
Masaki Shimizu, Yasuo Nakagishi, Natsumi Inoue, Mao Mizuta, Giyo Ko, Yutaka Saikawa, Tomohiro Kubota, Yuichi Yamasaki, Syuji Takei, Akihiro Yachie, Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clinical Immunology. ,vol. 160, pp. 277- 281 ,(2015) , 10.1016/J.CLIM.2015.06.005
Scott W. Canna, Julia Wrobel, Niansheng Chu, Portia A. Kreiger, Michele Paessler, Edward M. Behrens, Interferon‐γ Mediates Anemia but Is Dispensable for Fulminant Toll‐like Receptor 9–Induced Macrophage Activation Syndrome and Hemophagocytosis in Mice Arthritis & Rheumatism. ,vol. 65, pp. 1764- 1775 ,(2013) , 10.1002/ART.37958
U. Winkler, M. Jensen, O. Manzke, H. Schulz, V. Diehl, A. Engert, Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8) Blood. ,vol. 94, pp. 2217- 2224 ,(1999) , 10.1182/BLOOD.V94.7.2217.419K02_2217_2224
Randy Q Cron, Michele Paessler, Timothy Beukelman, Edward M Behrens, Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. The Journal of Rheumatology. ,vol. 34, pp. 1133- 1138 ,(2007)
Loredana Cifaldi, Giusi Prencipe, Ivan Caiello, Claudia Bracaglia, Franco Locatelli, Fabrizio De Benedetti, Raffaele Strippoli, Inhibition of Natural Killer Cell Cytotoxicity by Interleukin‐6: Implications for the Pathogenesis of Macrophage Activation Syndrome Arthritis & Rheumatism. ,vol. 67, pp. 3037- 3046 ,(2015) , 10.1002/ART.39295
Sjoukje J. C. van der Stegen, David M. Davies, Scott Wilkie, Julie Foster, Jane K. Sosabowski, Jerome Burnet, Lynsey M. Whilding, Roseanna M. Petrovic, Sadaf Ghaem-Maghami, Stephen Mather, Jean-Pierre Jeannon, Ana C. Parente-Pereira, John Maher, Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity? Journal of Immunology. ,vol. 191, pp. 4589- 4598 ,(2013) , 10.4049/JIMMUNOL.1301523
Yoshihito Kasahara, Akihiro Yachie, Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Critical Reviews in Oncology Hematology. ,vol. 44, pp. 283- 294 ,(2002) , 10.1016/S1040-8428(02)00119-1
David M. Barrett, David T. Teachey, Stephan A. Grupp, Toxicity management for patients receiving novel T-cell engaging therapies Current Opinion in Pediatrics. ,vol. 26, pp. 43- 49 ,(2014) , 10.1097/MOP.0000000000000043
JESSICA L. RECORD, TIMOTHY BEUKELMAN, RANDY Q. CRON, Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series The Journal of Rheumatology. ,vol. 38, pp. 180- 181 ,(2011) , 10.3899/JRHEUM.100726
Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori, Takako Miyamae, Syuji Takei, Naomi Iwata, Hiroaki Umebayashi, Takuji Murata, Mari Miyoshi, Minako Tomiita, Norihiro Nishimoto, Tadamitsu Kishimoto, Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan. The Journal of Rheumatology. ,vol. 41, pp. 759- 767 ,(2014) , 10.3899/JRHEUM.130690